LeonaBio annual return on equity
2020
2021
2022
2023
2024
2025
LeonaBio Return on Equity (ROE) Growth & History (LONA)
LeonaBio's return on equity was −290.81% for fiscal 2025.
View full LeonaBio company overviewLeonaBio annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −290.81% | −180.04 pp |
| 2024 | 2024-12-31 | −110.77% | −46.35 pp |
| 2023 | 2023-12-31 | −64.42% | −30.03 pp |
| 2022 | 2022-12-31 | −34.39% | −15.96 pp |
| 2021 | 2021-12-31 | −18.43% | −2.75 pp |
| 2020 | 2020-12-31 | −15.68% | — |
LeonaBio quarterly return on equity
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −45.86% | −25.76 pp |
| Q1 2026 | 2026-03-31 | −85.48% | −63.22 pp |
| Q4 2025 | 2025-12-31 | −303.76% | −274.46 pp |
| Q3 2025 | 2025-09-30 | −22.50% | +18.29 pp |
| Q2 2025 | 2025-06-30 | −20.10% | +8.16 pp |
| Q1 2025 | 2025-03-31 | −22.25% | −0.02 pp |
| Q4 2024 | 2024-12-31 | −29.30% | −10.15 pp |
| Q3 2024 | 2024-09-30 | −40.79% | −21.38 pp |
| Q2 2024 | 2024-06-30 | −28.26% | −13.32 pp |
| Q1 2024 | 2024-03-31 | −22.23% | −9.76 pp |
| Q4 2023 | 2023-12-31 | −19.15% | −7.03 pp |
| Q3 2023 | 2023-09-30 | −19.41% | −11.97 pp |
| Q2 2023 | 2023-06-30 | −14.94% | −6.59 pp |
| Q1 2023 | 2023-03-31 | −12.47% | −5.73 pp |
| Q4 2022 | 2022-12-31 | −12.12% | −7.15 pp |
| Q3 2022 | 2022-09-30 | −7.44% | −2.88 pp |
| Q2 2022 | 2022-06-30 | −8.35% | −4.44 pp |
| Q1 2022 | 2022-03-31 | −6.73% | −3.95 pp |
| Q4 2021 | 2021-12-31 | −4.97% | −2.09 pp |
| Q3 2021 | 2021-09-30 | −4.56% | +2.49 pp |
| Q2 2021 | 2021-06-30 | −3.91% | — |
| Q1 2021 | 2021-03-31 | −2.78% | — |
| Q4 2020 | 2020-12-31 | −2.89% | — |
| Q3 2020 | 2020-09-30 | −7.05% | — |
LeonaBio return on equity trends
Over the last five fiscal years, LeonaBio's return on equity decreased from −15.68% to −290.81%, a change of −275.13 percentage points. The latest reported quarter, Q2 2026, shows −45.86%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review LeonaBio source filings ↗